International Association for the Study of Lung Cancer (IASLC) shared a post on LinkedIn:
”How are EGFR+ NSCLC cases managed in the Netherlands?
In this episode of Lung Cancer Considered in Dutch, Dr. Lizza Hendriks moderates a conversation with Dr. Marthe Paats and Dr. Gerrina Ruiter to review diagnostic and treatment approaches for patients with EGFR-mutant NSCLC.
An Interesting Article about NSCLC on OncoDaily.